Visual field defects and antiepileptic treatment;Gesichtsfeldstorungen bei antiepileptikabehandlung

Nervenarzt

Volumn 70, Issue 6, 1999, Pages 552-555

  Stefan, H ^a   Bernatik, J ^b   Knorr, J ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

Drugs; Epilepsies; Visual field defects

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLOROQUINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIFENE; DIAZEPAM; DIGITALIS; ERGOTAMINE; ETHAMBUTOL; HEXACHLOROPHENE; METHOTREXATE; PHENOTHIAZINE; PHENYTOIN; TIAGABINE; VIGABATRIN; 4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; GABAPENTIN;

ANTICONVULSANT THERAPY; ARTICLE; DRUG SAFETY; EPILEPSY; HUMAN; INCIDENCE; PATHOGENESIS; VISUAL FIELD DEFECT; ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PERIMETRY; VISUAL DISORDER; VISUAL FIELD;

ACETIC ACIDS; ADOLESCENT; ADULT; AMINES; ANTICONVULSANTS; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PERIMETRY; VIGABATRIN; VISION DISORDERS; VISUAL FIELDS;

EID: 0032914512     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050479     Document Type: Article

References (13)

1. Beran R, Currie J, Plunkell M, Sanbach J (1998) Visual field constriction with new antiepileptic medication. Epilepsia 31 [Suppl 2]:6
2. Eke T, Lawden MC, Talbot JF (1997) Severe persistent visual field constriction associated with vigabatrine. Br Med J 3:311-380
3. Elder M (1992) Diazepam and it's effects and visual fields. Aust N Z J Ophthalmol 20:267-270
4. Korngut SE, Appen R, Choate J, Klein PHD (1982) Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Am Cancer Soc 50:1289-1293
5. Kälviäinen R, Mäntyjärvi M, Nikoskelainen E, Nousiainen I, Partanen J, Partanen K, Riekkinen PJ (1998) Visual field defects associated with initial vigabatrin monotherapy as compared with initial carbamazepine monotherapy. Epilepsia 39 [Suppl 2]:5
6. Krämer G, Bacher M, Blankenhorn V, Bredel-Geißler A, Jallon P, Goumaz M, Kaiser H, Scollo-Lavizzari G (1997) Vigabatrin-associated bilateral concentric visual field defects in four patients. Epilepsia 38 [Suppl 8]:5.035
7. Krämer G, Dorn T (1998) Gesichtsfeldausfälle unter Antiepileptika. Aktuel Neurol 25:123
8. Krauss GL, Johnson MA, Miller R (1998) Vigabatrine associated retinal cone system dysfunction electroretinogram and ophthalmologic findings. Neurology 60:1-9
9. Lorenz R, Cook H (1988) Visuelle Störungen durch Diphenylhydantoin: klinische und elektroophthalmologische Befunde. Klin Monatsbl Augenheilkd 192:244-248
10. Nielson NV, Syversen K (1986) Possible retinotoxis effects of carbamazepine. Acta Ophthalmol 64:278-290
11. Stefan H, Bernatik J, Knorr HLJ (in Druck) Visual field constriction and antiepileptic drug treatment, (in preparation)
12. Wacker W, Donoso L, Kalsow C, Organisciak D Yankeelov J (1977) Isolation, characterization and localization of a soluble uveopathogenic antigen from bovine retina. J Immunol 119:1949-1958
13. Wilson EA, Brodije MJ (1997) Severe persistent visual field constrictions associated with vigabatrine. Br Med J 314